Blending contentious and transactional expertise, Gide Loyrette Nouel A.A.R.P.I. operates comfortably across the pharmaceuticals, medical devices, telecommunications and mechanical innovations segments. The team is co-led by Raphaëlle Dequiré-Portier, a specialist in life sciences and mechanics litigation, Emmanuel Larere, who is well versed in biotech and electronics patents, and Jean-Hyacinthe de Mitry, who is adept in multijurisdictional validity and infringement matters alongside IP transactions. Marie-Ange Pozzo di Borgo represents clients of various industries in cross-jurisdictional patent disputes, both on the merits and in preliminary injunctions.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Billing & efficiency
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- ‘The team has been responsive and professional in our dealings so far.’
- ‘Excellent advocacy skills, creative with development of new arguments and options for the client.’
- 'Emmanuel Larere and Raphaëlle Dequiré-Portier are both excellent advocates. Marie-Ange Pozzi di Borgo is a rising star senior associate, superbly responsive, and very good at explaining issues in multiple languages.'
- ‘The team stands out for its rare combination of in-depth legal expertise and a practical understanding of industrial and scientific issues.'
- ‘We worked primarily with Raphaëlle Dequire-Portier and Célia Révy, whose dedication and complementary skills we greatly appreciate. Raphaëlle Dequire-Portier stands out for her remarkable expertise at the intersection of patent law and pharmaceutical regulations: she combines legal rigour, strategic vision, and a keen understanding of industrial issues.'
Key clients
- ASSIA
- Zuru
- Meril Life Sciences
- Amgen
- Boeringher Ingelheim
- Minebea (ex U-Shin)
- Thomson Licensing
- Vantiva
- Agri Advanced Technologies
- BMS
- Celltrion
- EDF
Work highlights
Representing Meril Life Sciences, a global medical device company operating in more than 100 countries, as the defendant in a new pan-European patent litigation filed by Edwards Lifesciences in France and before the UPC, regarding four of its patents on prosthetic heart valves and delivery systems for the implantation of such heart valves.
Representing the pharmaceutical companie BMS in a revocation proceeding brought by Teva, a generic drug manufacturer, to invalidate a patent and the corresponding supplementary protection certificate (SPC), which cover the compound apixaban.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Raphaëlle Dequiré-Portier; Emmanuel Larere; Jean-Hyacinthe de Mitry
Other key lawyers
Marie-Ange Pozzi di Borgo; Célia Révy